CidaraLogo (1).jpg
Cidara Therapeutics Announces Offering of Common Stock and Warrants
May 21, 2018 07:30 ET | Cidara Therapeutics, Inc.
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
novan logo.jpg
SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment
May 17, 2018 08:05 ET | Novan, Inc.
MORRISVILLE, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that data from the Company’s onychomycosis development program with SB208 gel...
CidaraLogo (1).jpg
Cidara Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 10, 2018 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
CidaraLogo (1).jpg
Cidara Announces Appointment of Chrysa Mineo as Independent Director
March 01, 2018 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the...
CidaraLogo (1).jpg
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
February 27, 2018 16:32 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
2019 logo_150x35_jpg.jpg
Novan to Present Positive Phase 2 Results for SB208 Antifungal Program at Winter Clinical Dermatology Conference
January 11, 2018 09:10 ET | Novan, Inc.
MORRISVILLE, N.C., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Phase 2 efficacy and safety data for SB208, a topical, silicone-based...
CidaraLogo (1).jpg
Cidara Provides Corporate Update and Reports Third Quarter 2017 Financial Results
November 08, 2017 16:01 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
CidaraLogo (1).jpg
Cidara Therapeutics to Report Third Quarter 2017 Financial Results and Provide Corporate Update
November 01, 2017 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will...
CidaraLogo (1).jpg
Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
October 19, 2017 09:00 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
CidaraLogo (1).jpg
Cidara Therapeutics to Present at Two Upcoming Conferences
September 18, 2017 16:05 ET | Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...